• Bank, I., Libourel, E.J., Middeldorp, S., Hamulyak, K., Van Pampus, E.C., Koopman, M.M., Prins, M.H., Van Der Meer, J. & Buller, H.R. (2005) Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. Journal of Thrombosis and Haemostasis, 3, 7984.
  • Bates, S.M., Greer, I.A., Hirsh, J. & Ginsberg, J.S. (2004) Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 627S644S.
  • Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van Der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 5, 6467.
  • Brenner, B., Hoffman, R., Blumenfeld, Z., Weiner, Z. & Younis, J.S. (2000) Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thrombosis and Haemostasis, 83, 9397.
  • Brouwer, J.L.P., Veeger, N.J.G.M., Kluin-Nelemans, H.C. & Van Der Meer, J. (2006) Multicausal pathogenesis of venous thromboembolism. Evidence from a study in families with hereditary deficiencies of protein S, protein C or antithrombin. Annals of Internal Medicine, 145, 807815.
  • Danneberg, J., Abbes, A.P., Bruggeman, B.J., Engel, H., Gerrits, J. & Martens, A. (1998) Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin). Clinical Chemistry, 44, 349351.
  • Den Heijer, M., Blom, H.J., Gerrits, W.B.J., Rosendaal, F.R., Haak, H.L., Wijermans, P.W. & Bos, G.M. (1995) Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet, 345, 882885.
  • Den Heijer, M., Koster, T., Blom, H.J., Bos, G.M., Briët, E., Reitsma, P.H., Vandenbroucke, J.P. & Rosendaal, F.R. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 344, 759761.
  • Foka, Z.J., Lambropoulos, A.F., Saravelos, H., Karas, G.B., Karavida, A., Agorastos, T., Zournatzi, V., Makris, P.E., Bontis, J. & Kotsis, A. (2000) Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Human Reproduction, 15, 458462.
  • Frezzato, M., Tosetto, A. & Rodeghiero, F. (1996) Validated questionnaire for the identification of previous personal or familial venous thromboembolism. American Journal of Epidemiology, 143, 12571265.
  • Gris, J.C., Mercier, E., Quere, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.L., Dauzat, M. & Mares, P. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood, 103, 36953699.
  • Kupferminc, M.J. (2003) Thrombophilia and pregnancy. Reproductive Biology and Endocrinology, 1, 111.
  • Kupferminc, M.J., Fait, G., Many, A., Lessing, J.B., Yair, D., Bar-Am, A. & Eldor, A. (2001) Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertension in Pregnancy, 20, 3544.
  • Meinardi, J.R., Middeldorp, S., De Kam, P.J., Koopman, M.M., Van Pampus, E.C., Hamulyak, K., Prins, M.H., Buller, H.R. & Van Der Meer, J. (1999) Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals of Internal Medicine, 130, 736739.
  • Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 22952306.
  • Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 36983703.
  • Rai, R.S., Regan, L., Chitolie, A., Donald, J.G. & Cohen, H. (1996). Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. British Journal of Obstetrics and Gynaecology, 103, 842844.
  • Sanson, B.J., Friederich, P.W., Simioni, P., Zanardi, S., Hilsman, M.V., Girolami, A., Ten Cate, J.W. & Prins, M.H. (1996) The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thrombosis and Haemostasis, 75, 387388.
  • Sanson, B.J., Simioni, P., Tormene, D., Moia, M., Friederich, P.W., Huisman, M.V., Prandoni, P., Bura, A., Rejto, L., Wells, P., Mannucci, P.M., Girolami, A., Buller, H.R. & Prins, M.H. (1999) The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood, 94, 37023706.
  • Stirling, Y., Woolf, L., North, W.R., Seghatchian, M.J. & Meade, T.W. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis, 52, 176182.
  • Stirrat, G.M. (1990) Recurrent miscarriage. Lancet, 336, 673675.
  • Vossen, C.Y., Preston, F.E., Conard, J., Fontcuberta, J., Makris, M., Van Der Meer, F.J., Pabinger, I., Palareti, G., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. & Rosendaal, F.R. (2004) Hereditary thrombophilia and fetal loss: a prospective follow-up study. Journal of Thrombosis and Haemostasis, 2, 592596.